Ahmed MD Hamdy
CIK 1458506 · CMO · last filed 2026-03-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$49.8K
Companies
3
Total Filings
23
Lifetime Open-Market Net
$250.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-29 | VINC | Grant (A) | — | $0 | EDGAR |
| 2022-06-27 | VINC | Buy (P) | +24,200 | $34.1K | EDGAR |
| 2022-02-16 | VINC | Grant (A) | — | $0 | EDGAR |
| 2021-12-27 | VINC | Buy (P) | +6,450 | $64.6K | EDGAR |
| 2021-06-30 | VINC | Buy (P) | +7,830 | $100.0K | EDGAR |
| 2020-12-28 | Vincerx Pharma, Inc. (VINCW) Delisted | Grant (A) | +1,618,199 | $0 | EDGAR |
| 2011-05-03 | — | Other (J) | +5,011 | $8.1K | |
| 2010-11-02 | — | Other (J) | +4,945 | $7.9K | |
| 2010-10-15 | — | Grant (A) | — | $0 | |
| 2010-10-07 | — | Mixed | — | -$112.0K |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.